Table 3.
In vitro cytotoxicity of isolated compounds from the combined fractions CSPE4/CSPE5.
| WI38 IC50 (µg/ml) |
J774 IC50 (µg/ml) |
IS (IC50 WI38/IC50 J774) |
|
|---|---|---|---|
| Compound 1 | 19.24 ± 0.55 (4.51 µM) | 12.60 ± 0.23 (2.96 µM) |
1.5∗∗∗ |
| Mixture of compounds 3a/3b | 16.50 ± 0.24 (3.6 µM) |
1.79 ± 0.03 (0.39 µM) | 9.2∗∗∗ |
| Camptothecin | 0.175 ± 0.08 (0.05 µM) |
0.011 ± 0.004 (0.0031 µM) |
15∗∗∗ |
Compound 1: lupeol; mixture of compounds 3a/3b: 25-hydroperoxycycloart-23-en-3β-ol and 24-hydroperoxycycloart-25-en-3β-ol; camptothecin: positive control; results are expressed as mean ± standard error of the mean (SEM) of six determinations and activity differences between cell lines are statistically defined for each compound with the Mann–Whitney or Wilcoxon signed-rank tests for comparison to the highest tested concentration (p < 0.005∗∗∗).